RecalledThisWeek Search
Medium risk Drugs & MedicationsClass II

Baxter Healthcare Corporation Recall

Daptomycin, in 0.9% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg/mL), 1,000 mg total, in 1000 mL Single Dose Container, Rx only, St

Updated August 6, 2026

Baxter Healthcare Corporation is recalling Daptomycin, in 0.9% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg/mL), 1,000 mg total, in 1000 mL Single Dose Container, Rx only, St. Hazard: CGMP Deviations

Is the Baxter Healthcare Corporation recalled? Yes. This product was recalled by FDA on August 6, 2026. Details below.

What is recalled

Daptomycin, in 0.9% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg/mL), 1,000 mg total, in 1000 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0718-12.

Am I affected

You may be affected if you own this product. Check the brand, model, and lot/date codes listed in the recall against your item.

What to do right now

Voluntary: Firm initiated

The hazard

CGMP Deviations

Brands affected

Baxter Healthcare Corporation
Source
FDA
Category
Drugs & Medications
Recall ID
fda-D-0821-2026
Classification
Class II
Recalled
August 6, 2026
Read the official notice

Get free recall alerts

New Drugs & Medications recalls, the moment they post.

Free forever. Unsubscribe anytime. We never sell your data.

More Drugs & Medications recalls